endometrial hyperplasia with atypia,
estrogen-progestin therapy in the 2 months before enrollment,
autoimmune diseases,
chronic, metabolic, systemic and endocrine disorders, including hyperandrogenism, hyperprolactinemia, diabetes mellitus and thyroid disease,
hypogonadotropic hypogonadism,
majors clinical conditions

NCT02361892_exc_T1
Condition
endometrial hyperplasia
NCT02361892_exc_T2
Condition
atypia
NCT02361892_exc_T3
Procedure
estrogen-progestin therapy
NCT02361892_exc_T4
Temporal
in the 2 months before enrollment
NCT02361892_exc_T5
Condition
autoimmune diseases
NCT02361892_exc_T6
Condition
onic, m orders, i
NCT02361892_exc_T7
Condition
abolic, s orders, i
NCT02361892_exc_T8
Condition
temic an orders, i
NCT02361892_exc_T9
Condition
endocrine disorders
NCT02361892_exc_T10
Condition
hyperandrogenism
NCT02361892_exc_T11
Condition
hyperprolactinemia
NCT02361892_exc_T12
Condition
diabetes mellitus
NCT02361892_exc_T13
Condition
thyroid disease
NCT02361892_exc_T14
Scope
hyperandrogenism, hyperprolactinemia, diabetes mellitus and thyroid disease
NCT02361892_exc_T15
Scope
chronic, metabolic, systemic and endocrine disorders
NCT02361892_exc_T16
Condition
hypogonadotropic hypogonadism
NCT02361892_exc_T17
Condition
majors clinical conditions